22175 ⎘
Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment; Use of macromolecular materials Polysaccharides
NANOSTRUCTURED LOW-IMMUNOGENIC BIOLOGICAL ARTIFICIAL BLOOD VESSEL AND PREPARATION METHOD THEREFOR
#2TRANSCATHETER PULMONARY FLOW RESTRICTOR
#3MODIFIED ALGINATES FOR ANTI-FIBROTIC MATERIALS AND APPLICATIONS
#4NEUROVASCULAR IMPLANTS AND DELIVERY SYSTEMS
#5TISSUE-PLASMINOGEN ACTIVATOR COATED CATHETER WITH HYDROGEL-CONTROLLED ELUTION
#6IMPLANTABLE MATERIAL IN CONTACT WITH BLOOD AND USES THEREOF
#7TO PROCESSES FOR IMMOBILISING BIOLOGICAL ENTITIES
#8Compositions Comprising Oxidized Cellulose
#9EMBOLIZATION WITH TRANSIENT MATERIALS
#10SURFACE-MODIFIED ANASTOMOSIS DEVICE
#11High anticoagulation ECMO and extracorporeal circulation consumable
#12ANTICOAGULANT COMPOUNDS AND METHODS AND DEVICES FOR THEIR USE
#13Processes for immobilising biological entities
#14Method for producing a fibrin-based bioartificial, primarily acellular construct, and the construct itself
#15Anticoagulant compounds and methods and devices for their use
#16Modified alginates for anti-fibrotic materials and applications
#17Prosthetic tissue valve and method of treating the same
#18ENGINEERED HEPARIN BIOACTIVE MATRIX FOR CLINICAL APPLICATION OF BLOOD CONTACTING SURFACE AND METHOD OF MANUFACTURING THE SAME
#19EMBOLIZATION WITH TRANSIENT MATERIALS
#20Immobilised biological entities
#21IMMOBILISING BIOLOGICAL ENTITIES
#22METHODS AND COMPOSITIONS FOR TREATING CHRONIC RHINOSINUSITIS
#23Cell impregnated sleeve for paracrine and other factor production
#24Compositions Comprising Oxidized Cellulose
#25Modified alginates for anti-fibrotic materials and applications
#26IMMOBILISING BIOLOGICAL ENTITIES
#27PROCESSES FOR IMMOBILISING BIOLOGICAL ENTITIES
#28Modified alginates for anti-fibrotic materials and applications
#29Modified alginates for anti-fibrotic materials and applications
#30New A-PRP Medical Device & Tissue Engineering Composition, Manufacturing Machines And Process
#31IMMOBILISED BIOLOGICAL ENTITIES
#32ANTI-THROMBOGENIC GRAFTS
#33Method for producing a fibrin-based bioartificial, primarily acellular construct, and the construct itself
#34Functionalized membranes for bioartificial organs
#35Immobilised biological entities
#36Thromboresistant-anticoagulant extracellular matrix
#37Modified alginates for anti-fibrotic materials and applications
#38Modified alginates for anti-fibrotic materials and applications
#39Use of alginate oligomers as blood anticoagulants
#40Immobilised biological entities
#41Cell impregnated sleeve for paracrine and other factor production
#42Anti-thrombogenic grafts
#43Modified alginates for anti-fibrotic materials and applications
#44Phosphoryl choline coating compositions
#45NEW A-PRP MEDICAL DEVICE & TISSUE ENGINEERING COMPOSITION, MANUFACTURING MACHINES AND PROCESS
#46Catheter lock solution formulations
#47Self assembled films for protein and drug delivery applications
#48Chitosan-based hemostatic textile
#49Immobilised biological entities
#50Aqueous Lock Composition Comprising Ethanol and a Polysaccharide Anticoagulant
#51Immobilization of an active agent on a substrate
#52ANTITHROMBIC COATINGS AND USES THEREOF
#53Coating for substrate
#54VASCULAR ACCESS DEVICES, METHODS, AND KITS
#55Novel Heparin Entities and Methods of Use
#56Medical tube
#57Chitosan-based hemostatic textile
#58Coating for a medical device having an anti-thrombotic conjugate
#59Methods of making and using surfactant polymers
#60Immobilised biological entities
#61Chitosan-based hemostatic textile
#62NOVEL HEPARIN ENTITIES AND METHODS OF USE
#63Heparin entities and methods of use
#64Compounds and method for coating surfaces in a hemocompatible manner
#65IMPLANTABLE MATERIAL COMPRISING CELLULOSE AND THE GLYCOPEPTIDE XYLOGLUCAN-GRGDS
#66Immobilised biological entities
#67Self-aggregating protein compositions and use as sealants
#68Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
#69Self Assembled Films for Protein and Drug Delivery Applications
#70Coating for a medical device having an anti-thrombotic conjugate
#71Methods of making and using surfactant polymers
#72METHODS OF MAKING AND USING SURFACTANT POLYMERS
#73Hemostatic compositions and methods for controlling bleeding
#74Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
#75Method of Modifying Blood Contact Material and Blood Contact Material Inhibited from Activating Granulocyte
#76COMPOSITIONS AND COATINGS FOR IMPLANTABLE MEDICAL DEVICES
#77COMPOSITIONS COMPRISING POROUS ARTICLES AND USES IN IMPLANTABLE MEDICAL DEVICES
#78COATINGS FOR IMPLANTABLE MEDICAL DEVICES
#79COATINGS FOR IMPLANTABLE MEDICAL DEVICES
#80Polymers for delivering nitric oxide in vivo
#81Supple tissue dressing assemblies, systems, and methods formed from softened hydrophilic polymer sponge structures such as chitosan
#82Hemostatic compositions and methods for controlling bleeding
#83Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
#84Polymers for delivering nitric oxide in vivo
#85Phosphoryl choline coating compositions
#86Compounds and method for coating surfaces in a haemocompatibe manner
#87Tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
#88Self-aggregating protein compositions and use as sealants
#89Methods of making and using surfactant polymers